Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Press

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Progress in Clinical and Biological Research|January 1, 1990
HER-2/neu oncogene amplification and expression in breast and ovarian cancersM F Press, L A Jones, W Godolphin, et al.
British Journal of Cancer|August 15, 2002
Heritable breast cancer in twinsT M Mack, A S Hamilton, M F Press, et al.
American Journal of Clinical Pathology|September 1, 1988
The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysisS Bacus, J L Flowers, M F Press, et al.
Hybridoma|January 8, 2000
Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapiesJ M Park, X Yang, J J Park, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1984
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycleM F Press, N Nousek-Goebl, W J King, et al.
Cancer Research|December 4, 2001
Germ-line HER-2 variant and breast cancer risk by stage of diseaseR McKean-Cowdin, L N Kolonel, M F Press, et al.
American Journal of Obstetrics and Gynecology|March 1, 1989
Comparison of the quantity of estrogen receptors in human endometrium and myometrium by steroid-binding assay and enzyme immunoassay based on monoclonal antibodies to human estrophilinE K Senekjian, M F Press, R R Blough, et al.
Cancer Research|December 1, 1995
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survivalB Saffari, L A Jones, A el-Naggar, et al.
Gynecologic Oncology|April 29, 2000
p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinomaA Schmider, C Gee, W Friedmann, et al.
Fertility and Sterility|September 1, 1994
Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative studyR A Miles, R J Paulson, R A Lobo, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Progress in Clinical and Biological Research|January 1, 1990
HER-2/neu oncogene amplification and expression in breast and ovarian cancersM F Press, L A Jones, W Godolphin, et al.
British Journal of Cancer|August 15, 2002
Heritable breast cancer in twinsT M Mack, A S Hamilton, M F Press, et al.
American Journal of Clinical Pathology|September 1, 1988
The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysisS Bacus, J L Flowers, M F Press, et al.
Hybridoma|January 8, 2000
Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapiesJ M Park, X Yang, J J Park, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 1, 1984
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycleM F Press, N Nousek-Goebl, W J King, et al.
Cancer Research|December 4, 2001
Germ-line HER-2 variant and breast cancer risk by stage of diseaseR McKean-Cowdin, L N Kolonel, M F Press, et al.
American Journal of Obstetrics and Gynecology|March 1, 1989
Comparison of the quantity of estrogen receptors in human endometrium and myometrium by steroid-binding assay and enzyme immunoassay based on monoclonal antibodies to human estrophilinE K Senekjian, M F Press, R R Blough, et al.
Cancer Research|December 1, 1995
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survivalB Saffari, L A Jones, A el-Naggar, et al.
Gynecologic Oncology|April 29, 2000
p21 (WAF1/CIP1) protein expression is associated with prolonged survival but not with p53 expression in epithelial ovarian carcinomaA Schmider, C Gee, W Friedmann, et al.
Fertility and Sterility|September 1, 1994
Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative studyR A Miles, R J Paulson, R A Lobo, et al.
Pageof 8